About Us  |  BVA-100  |  Investor Relations  |  IDANT Division  |  Contact Us
 

Welcome to DAXOR Corporation!

 
 

7/7/2010 - Daxor Announces that Rush University Medical Center of Chicago, IL Acquires BVA-100 Blood Volume Analyzer

  

5/27/2010 - Daxor Announces Publication of Review Article on Use of Blood Volume Analysis to Guide Ultrafiltration in the Management of Congestive Heart Failure

  

5/10/2010 - Daxor Corporation Announces First Quarter 2010 Earnings and Payment of a Dividend

  
 

______________________

 
     
  DAXOR Corporation Newsletter; Issue 1, March 2010  
  2009 Form 10-K  
  2009 Second Quarter Earnings  
  September 2009 10-Q  
  2009 Proxy Statement  
  2008 Annual Report  
 

DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility.


The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.

 

Find out more about the BVA-100 >

 

See where blood volume tests are being performed >

 

Watch San Antonio's KENS5 station feature on the BVA-100
(MPEG video; 19 MB) >


 

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806


© 2010 DAXOR Corporation. All Rights Reserved.